40
1 The origin of the synergistic effect of muramyldipeptide with endotoxin and peptidoglycan Margreet A. Wolfert 1 , Thomas F. Murray 2 , Geert-Jan Boons 3 , and James N. Moore 1 Department of Large Animal Medicine 1 ,and Department of Physiology & Pharmacology 2 , College of Veterinary Medicine, The University of Georgia, Athens, GA 30602, and Complex Carbohydrate Research Center 3 , The University of Georgia, 220 Riverbend Road, Athens, GA 30602 To whom correspondence should be addressed: Margreet A. Wolfert, Ph.D., Department of Large Animal Medicine, College of Veterinary Medicine, University of Georgia, Athens, GA 30602. Tel.: 706-542-6326; Fax: 706-542-8833; E-mail: [email protected]. Running Title: Synergistic effect of MDP with LPS and PGN. Copyright 2002 by The American Society for Biochemistry and Molecular Biology, Inc. JBC Papers in Press. Published on July 31, 2002 as Manuscript M204885200 by guest on January 31, 2018 http://www.jbc.org/ Downloaded from

1 The origin of the synergistic effect of muramyldipeptide with

  • Upload
    lyquynh

  • View
    216

  • Download
    0

Embed Size (px)

Citation preview

Page 1: 1 The origin of the synergistic effect of muramyldipeptide with

1

The origin of the synergistic effect of muramyldipeptide with endotoxin and peptidoglycan

Margreet A. Wolfert1, Thomas F. Murray2, Geert-Jan Boons3, and James N. Moore1

Department of Large Animal Medicine1,and Department of Physiology & Pharmacology2, College of Veterinary

Medicine, The University of Georgia, Athens, GA 30602, and

Complex Carbohydrate Research Center3, The University of Georgia, 220 Riverbend Road, Athens, GA 30602

To whom correspondence should be addressed: Margreet A. Wolfert, Ph.D., Department of

Large Animal Medicine, College of Veterinary Medicine, University of Georgia, Athens, GA

30602. Tel.: 706-542-6326; Fax: 706-542-8833; E-mail: [email protected].

Running Title: Synergistic effect of MDP with LPS and PGN.

Copyright 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

JBC Papers in Press. Published on July 31, 2002 as Manuscript M204885200 by guest on January 31, 2018

http://ww

w.jbc.org/

Dow

nloaded from

Page 2: 1 The origin of the synergistic effect of muramyldipeptide with

2

SUMMARY

Although the basis for the high mortality rate for patients with mixed bacterial infections is

likely to be multifactorial, there is evidence for a synergistic effect of muramyldipeptide (MDP)

with lipopolysaccharide (LPS) on the synthesis of proinflammatory cytokines by mononuclear

phagocytes. In this study, co-incubation of human Mono Mac 6 cells with MDP and either LPS

or peptidoglycan (PGN) resulted in an apparent synergistic effect on tumor necrosis factor-α

(TNF-α) secretion. Although incubation of cells with MDP alone produced minimal TNF-α, it

caused significant expression of TNF-α mRNA. These findings suggest that the majority of

TNF-α mRNA induced by MDP alone is not translated into protein. Furthermore, simultaneous

incubation of cells with MDP and either LPS or PGN resulted in TNF-α mRNA expression that

approximated the sum of the amounts expressed in response to MDP, LPS, and PGN

individually. These findings indicate that the apparent synergistic effect of MDP on TNF-α

production induced by either LPS or PGN is caused by removal of a block in translation of the

mRNA expressed in response to MDP. In subsequent studies, the effects of MDP alone and its

effect on the production of TNF-α by LPS and PGN were determined to be independent of

CD14, Toll-like receptor 2, and Toll-like receptor 4. These findings indicate that MDP acts

through receptor(s) other than those primarily responsible for transducing the effects of LPS and

PGN. Successful treatment of patients having mixed bacterial infections is likely to require

interventions that address the mechanisms involved in responses induced by a variety of bacterial

cell wall components.

by guest on January 31, 2018http://w

ww

.jbc.org/D

ownloaded from

Page 3: 1 The origin of the synergistic effect of muramyldipeptide with

3

INTRODUCTION

Bacteremia is a critical problem in intensive care units, accounting for high morbidity and

mortality rates. The mortality rate associated with bacteremia exceeds 30% (1,2). In a recent

12-year clinical study, gram-positive and gram-negative bacteria accounted for 46.9% and 31.5%

of bacteremic episodes in an intensive care unit, respectively, with gram-positive organisms

being cultured from more patients (3). Further, the incidence of combined infections increased

more than 4-fold over the 12-year period and was associated with a mortality rate exceeding

55%. Based on the fact that the majority of the deleterious effects of bacteremia are caused by

inflammatory responses to specific bacterial components, these findings suggest that the patient's

response to a mixture of gram-positive and gram-negative organisms may be heightened to the

detriment of the patient.

The two most commonly studied components of gram-positive and gram-negative bacterial

cell walls are peptidoglycan (PGN)2 and lipopolysaccharide (LPS)2, respectively. Although

gram-negative bacterial cell walls also contain PGN, its concentration is far greater in the walls

of gram-positive bacteria (4). Proinflammatory effects of these bacterial cell wall components

occur both in in vitro after treatment of mononuclear phagocytes and in in vivo after exposure of

whole animals, with cells and animals being more sensitive to LPS than to PGN (5).

The results of recent experimental studies provide evidence for a synergistic effect of LPS

with muramyldipeptide (MDP)2, the minimal structural subunit of PGN accounting for some of

its immunogenicity (6). However, the underlying mechanism of action for MDP has not been

fully elucidated. For example, there are discrepancies regarding the involvement of specific

receptors, with some investigators indicating that MDP exerts its synergistic effect in human

by guest on January 31, 2018http://w

ww

.jbc.org/D

ownloaded from

Page 4: 1 The origin of the synergistic effect of muramyldipeptide with

4

leukocytes in a CD14-dependent manner (7). Others indicate that the response is CD14- and

Toll-like receptor (TLR)2 4-independent in human monocytic cell lines and that MDP up-

regulates expression of one of the primary components (MyD88 mRNA) in the TLR-mediated

response to LPS (4).

We report here that MDP not only synergizes with LPS but also acts similarly with PGN, to

induce the synthesis of tumor necrosis factor (TNF)-α in the human monocytic cell line Mono

Mac 6. This synergistic effect of MDP with LPS or PGN was investigated in relation to the

expression and stability of TNF-α mRNA. Furthermore, the role of receptors (e.g., CD14 and

TLR2/4) known to be involved in mediating cellular activation in response to bacterial cell wall

components was studied.

by guest on January 31, 2018http://w

ww

.jbc.org/D

ownloaded from

Page 5: 1 The origin of the synergistic effect of muramyldipeptide with

5

EXPERIMENTAL PROCEDURES

Reagents- PGN from Staphylococcus aureus was obtained from BioChemika, MDP (N-

acetylmuramyl-L-alanyl-D-isoglutamine) from Calbiochem, E. coli 055:B5 LPS and [3H]E. coli

K12 LCD25 LPS from List Biological Laboratories, polymyxin B from Bedford Laboratories,

and actinomycin D from Sigma Chemicals. Affinity purified anti-CD14 antibodies MEM-18

(IgG1) and MY4 (IgG2b) were purchased from SANBIO b.v. and Coulter, respectively.

Functional grade purified anti-human TLR2 (clone TL2.1) and TLR4 (clone HTA125) antibodies

(IgG2a) were from Bioscience. Affinity purified mouse IgG1 (Sigma), IgG2b (Coulter), and

IgG2a (Sigma) were used as control antibodies. There were no effects of preincubation with

these control antibodies for MEM-18, MY4, or TLRs. PGN was assayed for endotoxin using the

Limulus Amoebocyte Lysate assay (BioWhittaker). No significant endotoxin contamination of

this preparation was detected (< 1 ng of endotoxin/mg).

Cell Maintenance- Mono Mac 6 cells, provided by Dr. H.W.L. Ziegler-Heitbrock (University

of Munich, Germany), were cultured in RPMI 1640 medium with L-glutamine (BioWhittaker)

supplemented with 100 u/ml penicillin, 100 µg/ml streptomycin, 1% OPI supplement (Sigma;

containing oxaloacetate, pyruvate and bovine insulin), and 10% fetal calf serum (FCS)2

(HyClone). The cells were maintained in a humid 5% CO2 atmosphere at 37oC. New batches of

frozen cell stock were grown up every 2 months and growth morphology evaluated. Before each

experiment, Mono Mac 6 cells were allowed to differentiate for 2 days in the presence of 10

ng/ml calcitriol (Sigma).

ELISA TNF- Cells were harvested by centrifugation and gently resuspended (106 cells/ml)

in prewarmed (37oC) medium. Cells were then incubated for 6 hours with different

by guest on January 31, 2018http://w

ww

.jbc.org/D

ownloaded from

Page 6: 1 The origin of the synergistic effect of muramyldipeptide with

6

combinations of stimuli in the presence or absence of polymyxin B or antibodies as described in

the Results section. At the end of the incubation period, cell supernatants were collected and

stored frozen (-80oC) until assayed for TNF-α protein. In the experiments with antibodies, the

cells were incubated with each antibody for 30 min at 4oC, before the stimuli were added.

Concentrations of TNF-α in culture supernatants were determined in duplicate by a solid

phase sandwich ELISA. Briefly, 96-well plates (Nalge Nunc International) were coated with

purified mouse anti-human TNF-α monoclonal antibody (mAb)2 (Pharmingen). TNF-α in

standards and samples was allowed to bind to the immobilized mAb for 2 hours at room

temperature. Biotinylated mouse anti-human TNF-α mAb (Pharmingen) was then added,

producing an antibody-antigen-antibody “sandwich”. After addition of avidin-horseradish

peroxidase conjugate (Pharmingen) and ABTS peroxidase substrate (Kirkegaard & Perry

Laboratories), a green color was produced in direct proportion to the amount of TNF-α present in

the sample. The reaction was stopped by adding peroxidase stop solution (Kirkegaard & Perry

Laboratories), and the absorbance was measured at 405 nm using a microplate reader (Dynatech

Laboratories). All data for TNF-α are presented as the means + SD of duplicate cultures. Each

experiment was repeated at least twice.

Evaluation of materials for contamination by LPS- To ensure that any increase in TNF-α

production was not caused by LPS contamination of the solutions containing the various stimuli,

the experiments were performed in the absence and presence of polymyxin B, an antibiotic that

avidly binds to the lipid A region of LPS, thereby preventing LPS-induced monokine production

(8). TNF-α concentrations in supernatants of cells preincubated with polymyxin B (1 µg/ml) for

30 minutes before incubation with E. coli O55:B5 LPS for 6 hours were reduced from 2,330 +

by guest on January 31, 2018http://w

ww

.jbc.org/D

ownloaded from

Page 7: 1 The origin of the synergistic effect of muramyldipeptide with

7

111 pg/ml to 10 + 7 pg/ml, whereas preincubation with polymyxin B had no effect on TNF-α

synthesis by cells incubated with PGN (~1,800 pg/ml) or MDP (~80 pg/ml). Therefore, LPS

contamination of the latter preparations was inconsequential.

Preparation of RNA and quantification of TNF- mRNA by real-time polymerase chain

reaction (PCR)2 analysis- Cells were harvested by centrifugation and gently suspended (1.25 x

106 cells/ml) in prewarmed (37oC) medium. In appropriate experiments, cells were incubated

first with antibody or media (control) for 30 min at 4oC. Cells were then incubated with the

indicated concentrations of the stimuli for 1.5 hours after which cells were harvested, and total

RNA was isolated using the StrataPrep Total RNA Miniprep Kit (Stratagene) according to the

manufacturer’s protocol.

TNF-α gene expression was quantified in a two-step reverse transcription-PCR (RT-PCR)2.

In the RT step, cDNA was reverse transcribed from total RNA samples (0.625 µg/50 µl) using

random hexamers from the TaqMan RT reagents (Applied Biosystems). In the PCR step, PCR

products were synthesized from cDNA (22.5 ng/20 µl) using the Taqman universal PCR master

mix and TaqMan PDARs for human TNF-α (Applied Biosystems). Measurements were done

using the ABI Prism 7900 HT sequence detection system (Applied Biosystems), according to the

manufacturer’s protocols. As an endogenous control for these PCR quantification studies, 18S

ribosomal RNA gene expression was measured using the TaqMan ribosomal RNA control

reagents (Applied Biosystems). Results represent means + SD of triplicate measurements. Each

experiment was repeated at least twice.

by guest on January 31, 2018http://w

ww

.jbc.org/D

ownloaded from

Page 8: 1 The origin of the synergistic effect of muramyldipeptide with

8

LPS binding assay- Kinetic analysis of the [3H]LPS discociation rate (off rate) from Mono

Mac 6 cells was performed by the method of Kitchens and Munford (9). Mono Mac 6 cells were

washed in ice-cold HNE buffer (20 mM HEPES, pH 7.4, 150 mM NaCl, 1 mM EDTA) and

preincubated for 30 min at 37oC in SEBDAF buffer (20 mM HEPES, pH 7.4, 150 mM NaCl, 1

mM EDTA, 300 µg/ml BSA, 10 mM NaN3, 2 mM NaF, 5 mM deoxyglucose) to deplete

intracellular ATP and prevent ligand internalization. The cells were then centrifuged,

resuspended in RPMI containing 300 µg/ml BSA, 10 mM NaN3, 2 mM NaF, and 5 mM

deoxyglucose (1 x 106 cells in 500 µl, final volume). [3H]LPS (final concentration 30 ng/ml),

was first mixed with FCS (final concentration 7.5%) as a source for LPS binding protein. It was

added to the cells and incubated with frequent mixing for 1 hour at 37oC to reach equilibrium.

Next, unlabeled LPS (final concentration 10 µg/ml) or a mixture of unlabeled LPS and MDP

(final concentrations 10 µg/ml and 100 µg/ml, respectively), mixed first with FCS (final

concentration 7.5%), were added to the cells. The cells were harvested at several time points.

To determine non-specific binding, unlabeled LPS alone or in combination with MDP was added

to the cells before addition of [3H]LPS. The cells were harvested by adding ice-cold HNE buffer

(500 µl), and centrifuging the mixtures at 15,000 rpm for 2 min at 4oC. The supernatant was

aspirated, and the cells were washed with 500 µl ice-cold HNE buffer. The cells were lysed in 5

ml liquid scintillation cocktail (Beckman Instruments Inc.), and the cell-associated 3H was

counted. Results represent means + SD of triplicate samples. The experiment was repeated with

similar results.

by guest on January 31, 2018http://w

ww

.jbc.org/D

ownloaded from

Page 9: 1 The origin of the synergistic effect of muramyldipeptide with

9

Data analysis- LPS and PGN concentration-response data for stimulation of TNF-α

production in Mono Mac 6 cells were analyzed using nonlinear least-squares curve fitting in

Prism (GraphPad Software, Inc.). These data were fit with the following logistic equation:

Y = Emax / (1 + (EC50/X)Hill slope),

where Y is the TNF-α response, X is the LPS or PGN concentration, Emax is the maximum

response2 and EC50 is the concentration of LPS or PGN producing 50% stimulation2.

[3H]LPS dissociation experiments were analyzed by fitting a monoexponential decay equation

to the data

Y = Y0 e –kt,

where Y is the amount of [3H]LPS bound at time t, Y0 is the amount of [3H]LPS bound at time

zero, t is time of dissociation2, and k is the dissociation rate constant2. Half-lives2 for [3H]LPS

dissociation in the presence and absence of MDP were calculated as

t1/2 = 0.693 / k.

by guest on January 31, 2018http://w

ww

.jbc.org/D

ownloaded from

Page 10: 1 The origin of the synergistic effect of muramyldipeptide with

10

RESULTS

Effect of MDP on the responses of Mono Mac 6 cells to LPS and PGN- The effect of a 30

minute preincubation of Mono Mac 6 cells with MDP on TNF-α secretion induced by a wide

concentration range of LPS and PGN was compared with incubation with either LPS or PGN

alone (Fig. 1). Preincubation of cells with MDP resulted in a LPS concentration-response curve

having a higher maximal level (a two-fold increase), whereas the EC50 and Hill slope values did

not differ significantly from those obtained in the absence of MDP. In the absence of MDP, the

maximum concentration of produced TNF-α in response to LPS was 1,477 pg/ml, with a Hill

slope of 2.7 and an LPS EC50 of 13.2 ng/ml. Pretreatment with MDP increased the maximum

level of LPS-induced TNF-α production to 3,003 pg/ml; the Hill slope and EC50 were 3.1 and 8.6

ng/ml, respectively. Stimulation with MDP alone resulted in a TNF-α concentration of 71 pg/ml.

Similar results were obtained when cells were preincubated with MDP followed by PGN (Fig.

1b). The maximum level of TNF-α after incubation with PGN alone was 3,313 pg/ml with a Hill

slope of 1.1 and a PGN EC50 of 26.1 µg/ml. Preincubation with MDP yielded a maximum level

of 5,469 pg/ml, a Hill slope of 1.2, and an EC50 of 22.4 µg/ml. These results, derived from four-

parameter logistic fits to the data, demonstrate that the singular observable effect of MDP is to

increase the maximum TNF-α responses to LPS or PGN in the absence of an influence on their

respective potencies.

In addition to the experiments presented above, in which Mono Mac 6 cells were incubated

with MDP before addition of LPS or PGN, experiments also were performed in which MDP was

added simultaneously with LPS or PGN. Simultaneous treatment of Mono Mac 6 cells with

MDP and LPS or PGN produced the same increase in TNF-α secretion (data not shown),

suggesting that pretreatment was not necessary for the effect of MDP. Further, we performed

several experiments in which the cells were first exposed to MDP for 10 min or 20 min, washed

by guest on January 31, 2018http://w

ww

.jbc.org/D

ownloaded from

Page 11: 1 The origin of the synergistic effect of muramyldipeptide with

11

and then exposed to either LPS or PGN. The effect of exposure to MDP for only 10 min on

TNF-α concentration was more than additive, although not as dramatic as that occurring with

simultaneous and continuous treatment of the cells with MDP and LPS or PGN (data not shown).

We also performed experiments to determine if preincubation with MDP had a synergistic effect

with subsequent exposure to a second dose of MDP. In these experiments, the response was

simply additive (data not shown).

To rule out the possibility that Mono Mac 6 cells incubated with MDP produce TNF-α that

remains associated with the cells and was not secreted, TNF-α concentrations in the supernatant

were compared with total (cell-associated and secreted) TNF-α concentrations. Incubation of

cells with LPS, PGN, MDP, MDP plus LPS, and MDP plus PGN, produced only small amounts

of TNF-α that remained cell-associated; total TNF-α concentrations were indistinguishable from

those in the supernatants (data not shown).

Induction of TNF- mRNA by LPS, PGN, and MDP- TNF-α production in response to LPS is

controlled both at the transcriptional and post-transcriptional levels (10-12). To study whether

the synergistic induction of Mono Mac 6 cells by MDP is controlled at the level of gene

transcription, TNF-α mRNA expression was measured after treatment with medium, LPS or

PGN alone, or in combination with MDP. The effects of LPS and PGN each were determined at

their lowest concentrations causing maximal TNF-α protein production (i.e., LPS 30 ng/ml; PGN

100 µg/ml). Data presented in Fig. 2a indicate that incubation with LPS or PGN results in

similar levels of TNF-α mRNA. Incubation with MDP (100 µg/ml) resulted in a 10-fold increase

in TNF-α gene expression compared with control cells, although this was less than that caused

by LPS or PGN. The same concentration of MDP caused very low levels of TNF-α protein

by guest on January 31, 2018http://w

ww

.jbc.org/D

ownloaded from

Page 12: 1 The origin of the synergistic effect of muramyldipeptide with

12

secretion compared with LPS or PGN. Simultaneous treatment of cells with MDP and either

LPS or PGN resulted in further enhancement of TNF-α mRNA expression, which appears to

represent the additive effect of additing MDP and LPS or PGN individually. In contrast,

concentrations of TNF-α protein in the supernatants from the same samples, even after only 90

min exposure, were suggestive of a pronounced synergistic effect of MDP with either LPS or

PGN (Fig. 2b).

In addition to the experiment presented above, in which Mono Mac 6 cells were stimulated

for 90 min before RNA extraction, the same experiments were also performed in which RNA

was extracted after 30 min, 60 min, and 120 min of stimulation (Table 1). In all cases, only a

small amount of mRNA was expressed after 30 min. Stimulation with LPS or PGN produced

maximal mRNA expression at 60 min, whereas stimulation with MDP or MDP in combination

with LPS or PGN reached their maximal values at 90 min. TNF-α mRNA expression was

reduced markedly by 120 min. Varying the incubation period did not alter the finding that

simultaneous treatment of cells with MDP and either LPS or PGN resulted in an additive effect

on TNF-α mRNA expression.

Comparison of MDP with LPS on TNF- mRNA expression and TNF- protein concentration-

After determining that incubation of cells with MDP at 100 µg/ml resulted in TNF-α gene

expression but minimal protein translation, we wondered if this effect might be dependent on

MDP concentration and if the degree of mRNA expression in response to MDP might be

insufficient to result in protein translation. To address this question, Mono Mac 6 cells were

incubated for 90 min with medium alone as control, LPS ranging from 0.01 to 100 ng/ml, or

MDP ranging from 0.01 to 300 µg/ml, in an effort to determine if there were concentrations of

by guest on January 31, 2018http://w

ww

.jbc.org/D

ownloaded from

Page 13: 1 The origin of the synergistic effect of muramyldipeptide with

13

LPS causing TNF-α mRNA expression but not translation, and to determine the dose

dependency for the effects of MDP. Even after only 90 min, there was a clear dose response for

LPS, both for TNF-α protein production and the TNF-α mRNA expression (Fig. 3). A plateau in

TNF-α protein production was evident at 30 ng/ml LPS, a finding that was in agreement with

data presented in Fig. 1 where cells were stimulated for 6 hours. However, a plateau was not

observed for TNF-α RNA expression. Although incubation with MDP at 100 µg/ml resulted in

TNF-α protein production comparable with that caused by 0.01 – 0.1 ng/ml LPS, TNF-α mRNA

expression induced by MDP was comparable with that caused by 1 ng/ml LPS. These results

demonstrate that the amount of TNF-α mRNA expressed when cells are incubated with MDP

was not a limiting factor for subsequent protein translation.

Incubation of the cells with MDP yielded dose dependent increases in both TNF-α protein

production and TNF-α mRNA expression. Although TNF-α protein concentrations barely

exceeded background values even at a MDP concentration of 300 µg/ml (Fig. 3a), TNF-α mRNA

expression was increased by MDP at 10 µg/ml and reached a maximum at 100 µg/ml (Fig. 3b).

Consequently, we used MDP at 100 µg/ml in the remainder of the study.

Determination of half-life of TNF- mRNA- The above results suggest that the apparent

synergistic effects of MDP and either LPS or PGN were caused by different patterns of

regulation of mRNA translation. It was reported recently that synergistic production of TNF-α

by macrophages exposed to a combination of bacterial DNA and LPS was at least in part caused

by prolonged half-life of TNF-α mRNA (13). To investigate if this was the case for Mono Mac 6

cells exposed to a combination of MDP and either LPS or PGN, the half-life of TNF-α mRNA

was determined in Mono Mac 6 cells exposed to medium, LPS or PGN alone, or in combination

by guest on January 31, 2018http://w

ww

.jbc.org/D

ownloaded from

Page 14: 1 The origin of the synergistic effect of muramyldipeptide with

14

with MDP. After a 90 min exposure, further transcription was inhibited by treating the cells with

actinomycin D (10 µg/ml). Total RNA was isolated at various time points after the addition of

actinomycin D, and TNF-α mRNA expression was measured by RT-PCR. The half-lives of

TNF-α mRNA in Mono Mac 6 cells stimulated with LPS, PGN, MDP, MDP plus LPS, and MDP

plus PGN were 14.3, 14.6, 11.5, 14.1, and 13.4 min, respectively (Fig. 4). The half-life of TNF-

α after stimulation with MDP alone was slightly shorter compared with the other stimuli, but the

half-lives of the combinations of MDP and LPS or PGN did not differ significantly from those of

LPS or PGN alone. Therefore, the effect of MDP with either LPS or PGN on release of TNF-α

cannot be explained by altered stability of TNF-α mRNA. Consequently, other post-

transcriptional factors must be responsible for the effect.

Effect of anti-CD14 mAbs on the synergistic effect of MDP- The fact that maximal TNF-α

mRNA expression for cells incubated with LPS or PGN occurred at 60 min, whereas maximal

mRNA expression for cells incubated with MDP alone or MDP with either LPS or PGN

occurred at 90 min suggests that activation of gene expression by MDP might occur through a

different route than LPS and PGN. To address this question, we performed experiments to

explore the possibility that different receptors are involved in the response of the cells to MDP

and either LPS or PGN. Two anti-CD14 mAbs MY4 and MEM-18 were used to assess the

involvement of CD14. It has been reported previously that the binding of LPS and PGN to

CD14 involves amino acids 51-64 or 57-64 in the N-terminal region of the receptor (14,15).

MEM-18, with its epitope at residues 57-64, is an anti-CD14 mAb specific for this region. The

epitope of MY4 is located closer to the N-terminal end of CD14 at amino acids 34-44. MY4 is

quite effective in inhibiting binding of both LPS and sPGN to soluble CD14 (14). In

by guest on January 31, 2018http://w

ww

.jbc.org/D

ownloaded from

Page 15: 1 The origin of the synergistic effect of muramyldipeptide with

15

experiments performed in our laboratory, both MEM-18 and MY4 completely neutralized the

effect of LPS. Whereas the effect of PGN was reduced by 86% and 54% by MEM-18 and MY4,

respectively (Fig. 5). We have previously reported that increasing the concentration of these

mAbs did not further increase their blocking effect on PGN (16). Even when LPS appeared to be

completely blocked by the anti-CD14 mAbs, the presence of MDP resulted in significant

amounts of TNF-α secretion (Fig. 5a). A similar effect of MDP on the response to PGN was

observed, even when the effects of PGN alone were partially blocked with the anti-CD14 mAbs

(Fig. 5b). These results suggest that the effect of MDP on the subsequent response to LPS and

PGN was CD14-independent.

Expression of TNF-α mRNA was determined for cells incubated for 90 min with medium

(control), LPS or PGN alone, or in combination with MDP in the absence or presence of MY4.

Whereas LPS-induced expression of TNF-α mRNA was almost completely abolished by MY4,

this antibody had minimal effect on the responses to PGN or MDP alone, and the additive effects

of MDP on the response to either LPS or PGN persisted in the presence of MY4 (Table 2).

These results provide further evidence that this effect of MDP was CD14-independent.

Influence of TLR4 and TLR2 on synergism of MDP with LPS and PGN- TLR 2 and 4 have

been implicated as critical receptors responsible for initiation of signaling events and cellular

activation in response to bacterial cell wall components (17). For instance, there is compelling

information that TLR4 plays a critical role in LPS-induced cell signaling and serves as a cell-

surface co-receptor for CD14. These two receptors are necessary for LPS-mediated NF-κB

activation and subsequent cellular events (18). Although incubation with the mAb directed

against TLR4 reduced the effect of LPS by 80% (Fig. 6), it did not affect the synergism between

by guest on January 31, 2018http://w

ww

.jbc.org/D

ownloaded from

Page 16: 1 The origin of the synergistic effect of muramyldipeptide with

16

MDP and LPS. MDP increased LPS-induced synthesis of TNF-α by 3.3-fold in the absence of

the anti-TLR4 mAb, and by 3.7-fold in the presence of the antibody. These findings provide

evidence that the synergism of MDP with LPS was TLR4-independent.

The results of recent studies suggest that TLR2 is involved in cellular responses to a wide

variety of infectious pathogens and their products, including PGN (17). Incubation of cells with

the mAb against TLR2 reduced the effect of PGN by 55% (Fig. 7). In the absence of the anti-

TLR2 mAb, MDP increased PGN-induced synthesis of TNF-α protein by 2.4-fold. Similarly,

PGN-induced TNF-α protein production was increased 2.0-fold in cells co-incubated with MDP

and the anti-TLR2 mAb. These findings suggest that the synergistic effect of MDP on the

cellular response to PGN was TLR2-independent.

Further, TNF-α mRNA expression was determined for cells incubated for 90 min with

medium (control), LPS or PGN alone, or in combination with MDP in the absence or presence of

anti-TLR2 or anti-TLR4 mAb (Table 3). Neither the anti-TLR2 nor the anti-TLR4 mAbs

reduced TNF-α mRNA expression in response to MDP. Furthermore, the additive effects of

MDP on expression of TNF-α mRNA induced by either LPS or PGN persisted in the presence of

the anti-TLR mAbs, providing additional evidence that MDP exerts its effect independent of

TLR2 and TLR4.

Effect of MDP on the [3H]LPS off rate from Mono Mac 6 cells- Based on the above results

suggesting that MDP exerts its effects independent of CD14, TLR2, and TLR4, we considered

the possibility that MDP might alter the interaction of LPS or PGN with these cell surface

receptors. To investigate the possibility that MDP might exert an allosteric action to increase the

affinity of LPS binding to the cell surface, the dissociation rate of LPS from the Mono Mac 6

cells was compared in the absence and presence of MDP (Fig. 8). The k of LPS was 0.0056 +

by guest on January 31, 2018http://w

ww

.jbc.org/D

ownloaded from

Page 17: 1 The origin of the synergistic effect of muramyldipeptide with

17

0.0025 in the absence of MDP and 0.0061 + 0.0023 in the presence of MDP. The t1/2 of LPS

alone (125 min) was not appreciably different from that of LPS in the presence of MDP (115

min).

by guest on January 31, 2018http://w

ww

.jbc.org/D

ownloaded from

Page 18: 1 The origin of the synergistic effect of muramyldipeptide with

18

DISCUSSION

In this study, we investigated the underlying mechanism for the apparent synergistic effect of

MDP on TNF-α production induced by either LPS or PGN. Co-incubation of Mono Mac 6 cells

with MDP and LPS yielded supernatant concentrations of TNF-α that were consistent with a

synergism between the two bacterial components. We observed the same effect with co-

incubation of the cells with MDP and PGN, a finding that has not been reported previously.

Incubation of Mono Mac 6 cells with LPS or PGN alone, showed a clear dose response for LPS

and PGN starting at 2 ng/ml and 2 µg/ml, respectively. Concentrations of LPS (30 ng/ml) and

PGN (100 µg/ml) resulted in peak supernatant concentrations of TNF-α, which exceeded 1,400

pg/ml and 3,300 pg/ml, respectively. In contrast, incubation of the cells with MDP alone at

concentrations up to 200 µg/ml resulted only in slight increases in supernatant concentrations of

TNF-α. The addition of MDP to either LPS or PGN resulted in substantial increases in TNF-α

compared with LPS or PGN alone. This apparent synergistic effect was obvious with different

concentrations of LPS and PGN, was evident after as little as 90 min of incubation, and was

maintained throughout the 6-hour incubation period. The presence of MDP significantly

increased the maximum value of the dose response curve for TNF-α secretion in response to LPS

or PGN, without changing either the Hill slope or the EC50. The primary effect of MDP was

therefore to increase the maximum TNF-α response to LPS or PGN, which was not consistent

with an allosteric action on either the LPS or PGN recognition site.

Others have reported a synergistic effect of muramyl peptides with LPS. Flak et al. reported

synergistic interactions between a naturally occurring PGN fragment (muramyl peptide) from

Bordetella pertussis and LPS in the induction of inflammatory processes (induction of

interleukin (IL)2-1a, type II (inducible) nitric oxide synthase, nitric oxide production, and

inhibition of DNA synthesis) within hamster trachea epithelial cells (19). Yang et al. reported

by guest on January 31, 2018http://w

ww

.jbc.org/D

ownloaded from

Page 19: 1 The origin of the synergistic effect of muramyldipeptide with

19

the synergistic effect of MDP with LPS or lipoteichoic acid to induce inflammatory cytokine IL-

8 in human monocytic cells in culture (4). Wang et al. reported that co-administration of PGN or

MDP with LPS caused significantly increased concentrations of TNF-α and IL-6 in cultures of

whole human blood, whereas the release of IL-10 was not influenced (7). In contrast, we

observed that TNF-α concentration in the supernatant of Mono Mac 6 cells co-incubated with the

combination of LPS and PGN were only additive (data not shown). A possible explanation for

this discrepancy is that we used insoluble PGN to eliminate potential effects of smaller PGN

fragments on the responses being measured. Because Wang et al. used a sonicated preparation

of PGN, their PGN preparation may have included some smaller fragments that might act like

MDP. Another difference between the two studies is the type of cell used; this may account for

the differences noted. We report here for the first time that MDP, which is the minimum active

fragment of PGN adjuvants (6), also synergizes with PGN in TNF-α production.

A unique finding of this study was that TNF-α mRNA expression showed a completely

different profile than TNF-α protein production. Incubation of the Mono Mac 6 cells with MDP

alone increased TNF-α mRNA, and co-incubation of the cells with MDP and either LPS or PGN

resulted in TNF-α mRNA expression that approximated the sum of the message generated in

response to MDP and either LPS or PGN alone. Although the additive effect on TNF-α mRNA

expression was maximal at 90 min, the same trend was apparent regardless of the incubation

period. With these data regarding the effects of MDP on TNF-α mRNA expression, the

concentration of TNF-α protein simply reflects the additive effects of MDP and either LPS or

PGN and not a synergistic interaction between these toxins. In short, co-incubation of MDP with

either LPS or PGN increases TNF-α gene expression and TNF-α protein production to the same

by guest on January 31, 2018http://w

ww

.jbc.org/D

ownloaded from

Page 20: 1 The origin of the synergistic effect of muramyldipeptide with

20

extent. Therefore, we conclude that TNF-α mRNA induced by MDP alone is not translated and

that the impediment in translation is circumvented by the presence of either LPS or PGN.

Having identified the lack of correlation between expression of TNF-α mRNA and TNF-α

protein induced by MDP and the subsequent responses to either LPS or PGN, we explored

whether MDP mediates its effect through different cell surface receptors than LPS and PGN. It

is well accepted that LPS and PGN initiate the production of proinflammatory mediators by

interacting with the cluster differentiation antigen CD14 (20-23). CD14 is a

glycosylphosphatidylinositol-anchored protein lacking transmembrane and cytoplasmic domains.

There is compelling evidence that LPS and PGN transmit their signals via individual members of

the TLR family, TLR4 (24,25) and TLR2 (26,27), respectively. An intermediary protein (MD-2)

is required for interactions involving LPS, CD14, and TLR4 (28).

In our studies we utilized two different anti-CD14 mAbs, MY4 and MEM-18, each of which

completely blocked the response to LPS. In contrast, these antibodies only partially inhibited

PGN-induced TNF-α production. However, neither antibody affected the apparent synergistic

effect of MDP with either LPS or PGN, suggesting that LPS and PGN in the presence of

antibodies that block CD14 were still able to initiate translation of the TNF-α mRNA induced by

MDP. The latter finding indicates that the effect of MDP is CD14 independent. This CD14-

independence was further confirmed by enhanced expression of TNF-α mRNA expression in

response to MDP in the presence of MY4. The finding that PGN-induced synthesis of TNF-α

was only partially blocked by MY4 and MEM-18 in this study was not completely unexpected.

Dziarski et al. have reported that MEM-18 almost completely inhibited binding of soluble (s)2

CD14 to sPGN, when sPGN was immobilized on agarose (14). However, we determined in a

by guest on January 31, 2018http://w

ww

.jbc.org/D

ownloaded from

Page 21: 1 The origin of the synergistic effect of muramyldipeptide with

21

previous study that PGN-induced TNF-α protein production in Mono Mac 6 cells could only be

partially blocked by anti-CD14 mAbs, suggesting that PGN exerts its effect through CD14 and

another unidentified receptor (16). This latter finding corroborates the inability of MY4 and

MEM-18 to completely block the effects of PGN in the present study. The unidentified receptor

could be TLR2, which may be activated by PGN independent of CD14 (29).

Unfortunately, commercially available anti-TLR mAbs do not completely block the effects of

either LPS or PGN, probably because of partial neutralization by these antibodies. Nevertheless,

the finding that these mAbs against TLR2 and TLR4 do not affect the apparent synergistic effect

of MDP with either LPS or PGN, strongly suggests that the effect of MDP is TLR2- and TLR4-

independent. The strength of this conclusion was increased by the lack of effect of either the

anti-TLR2 or the anti-TLR4 mAb on TNF-α mRNA expression by cells incubated with MDP.

Additional findings in the present study supporting our contention that MDP acts through

receptor(s) other than those utilized by LPS and PGN are the following: (1) the fact that MDP

increased the production of TNF-α protein induced by concentrations of LPS or PGN that by

themselves already caused maximal TNF-α production, (2) the observation that maximal TNF-α

mRNA expression occurs later when cells are incubated either with MDP alone or with MDP

combined with either LPS or PGN than after stimulation with either LPS or PGN alone, and (3)

the fact that the dissociation rate of LPS did not change in the presence of MDP suggests that

MDP does not alter the interaction of LPS with its cell surface receptor, inasmuch as such an

allosteric effect would have influenced [3H]LPS dissociation kinetics.

Our findings suggesting that MDP acts through receptors other than those utilized by LPS

and PGN are in agreement with results reported for hamster tracheal epithelial cells and another

monocytic cell line (4,19). Although our finding that MDP acts independently of CD14 appears

by guest on January 31, 2018http://w

ww

.jbc.org/D

ownloaded from

Page 22: 1 The origin of the synergistic effect of muramyldipeptide with

22

to contradict an earlier report that MDP binds to CD14 and prevents the binding of FITC-labeled

sPGN to human monocytes (30), the amount of MDP required to inhibit sPGN binding in that

study was very high, indicating that MDP bound to those cells with low-affinity. More recently,

Dziarski et al. reported that sCD14 can bind to MDP when coupled to agarose and that this

binding could not be inhibited by monomeric sMDP (14). Those investigators concluded that

polymeric, aggregated or solid-bound PGN or MDP is needed for CD14 binding, which is in

agreement with our findings that the effect of MDP is CD14-independent.

What remains to be determined are the mechanism(s) responsible for inhibiting translation of

the TNF-α mRNA expressed in response to MDP alone and the pathway of cellular activation

induced by MDP. It is well known that the synthesis of TNF-α is tightly controlled at many

different levels and is subject to several negative feedback mechanisms (11,31). For example,

post-transcriptional regulation of TNF-α production is mediated by the AU-rich element located

in the TNF-α mRNA 3’ untranslated region, which controls its translation and stability (32).

Metabolism of the 3’ poly(A) tail region of TNF-α mRNA plays a critical regulatory function in

TNF-α translation (33). In unstimulated, but adherent cells, shortening of the length of the

poly(A) tail prevents the initiation of TNF-α translation. This process is reversed by LPS,

allowing synthesis of translatable polyadenylated TNF-α mRNA. It is possible that MDP lacks

the ability to exert the same effect as LPS, rendering mRNA transcribed in response to MDP in a

form that requires an additional stimulus (e.g., LPS) in order for protein translation to occur. The

end result of cellular activation by LPS or PGN is up-regulation of more than 120 genes,

including differential activation of MAP kinases and slightly different patterns of gene activation

by guest on January 31, 2018http://w

ww

.jbc.org/D

ownloaded from

Page 23: 1 The origin of the synergistic effect of muramyldipeptide with

23

(34). It is possible that activation of some of these genes are important for translational control

of TNF-α production and are not activated by MDP alone.

In an effort to explain the apparent synergistic effect of MDP and LPS on TNF-α protein

production, some possibilities have been addressed by other investiators. Wang et al. reported a

twofold increase in surface expression of CD14 on monocytes and suggested that both PGN and

MDP prime leukocytes for LPS-induced release of pro-inflammatory cytokines (7). However,

this effect could not explain the observed synergism between PGN or MDP and LPS, as up-

regulation of CD14 up-regulation occurred after the synergistic effect was evident. Other

investigators have suggested involvement of MyD88, an adapter molecule essential for cell

signaling events initiated via the TLR family (35). In those studies, MDP and LPS individually

up-regulated MyD88 mRNA expression in THP-1 cells, but there was no synergistic up-

regulation of MyD88 mRNA in cells incubated with the combination of MDP and LPS (4).

Furthermore, the up-regulation of MyD88 that was detected, occurred later than the synergistic

effect and so could not account for the synergism. In this study, we have shown that the inability

to translate mRNA induced by MDP is not due to alterations in mRNA stability. We also

determined that there were no differences in transport between TNF-α induced by MDP and LPS

or PGN, as secreted TNF-α concentrations were indistinguishable from total TNF-α

concentrations.

In summary, we have demonstrated for the first time that MDP induces TNF-α gene

expression, without significant TNF-α translation. Furthermore, the block in translation is

removed in the presence of LPS and PGN, thereby accounting for the apparent synergistic effect

of MDP on TNF-α protein production. The amount of TNF-α protein produced in response to

by guest on January 31, 2018http://w

ww

.jbc.org/D

ownloaded from

Page 24: 1 The origin of the synergistic effect of muramyldipeptide with

24

the combination of either MDP and LPS or MDP and PGN is as expected in light of the amount

of TNF-α mRNA expressed individually in response to MDP, LPS, or PGN. Furthermore, we

have demonstrated that the effect of MDP alone and its apparent synergism with either LPS or

PGN is CD14-, TLR2- and TLR4-independent. Thus, we conclude that MDP exerts its effects

via different receptors than those responsible for the effects of LPS and PGN. Taken in the

context of reports documenting the deleterious effects of MDP in animals subjected to

experimentally induced septicemia (36) and the fact that antimicrobial drugs exert their effects

by causing the breakdown of bacterial cell wall components such as PGN (37), the results of the

current study underscore the importance of considering both serum concentrations of

inflammatory mediators as well as gene expression profiles when interpreting findings associated

with septicemia.

by guest on January 31, 2018http://w

ww

.jbc.org/D

ownloaded from

Page 25: 1 The origin of the synergistic effect of muramyldipeptide with

25

REFERENCES

1. Roberts, F. J., Geere, I. W., and Coldman, A. (1991) Rev. Infect. Dis. 13, 34-46

2. Pittet, D., Tarara, D., and Wenzel, R. P. (1994) J.A.M.A. 271, 1598-1601

3. Crowe, M., Ispahani, P., Humphreys, H., Kelley, T., and Winter, R. (1998) Eur. J. Clin.

Microbiol. Infect. Dis. 17, 377-384

4. Yang, S., Tamai, R., Akashi, S., Takeuchi, O., Akira, S., Sugawara, S., and Takada, H.

(2001) Infect. Immun. 69, 2045-2053

5. Lichtman, S. N., Wang, J., Schwab, J. H., and Lemasters, J. J. (1994) Hepatology 19,

1013-1022

6. Baschang, G. (1989) Tetrahedron 45, 6331-6360

7. Wang, J. E., Jorgenson, P. F., Ellingsen, E. A., Almlof, M., Thiemermann, C., Foster, S.

J., Aasen, A. O., and Solberg, R. (2001) Shock 16, 178-182

8. Tsubery, H., Ofek, I., Cohen, S., and Fridkin, M. (2000) Biochemistry 39, 11837-11844

9. Kitchens, R. L., and Munford, R. S. (1995) J. Biol. Chem. 270, 9904-9910

10. Biragyn, A., and Nedospasov, S. A. (1995) J. Immunol. 155, 674-683

11. Beutler, B. (1992) Am. J. Med. Sci. 303, 129-133

12. Kontoyiannis, D., Pasparakis, M., Pizarro, T. T., Cominelli, F., and Kollias, G. (1999)

Immunity 10, 387-398

13. Gao, J. J., Xue, Q., Papasian, C. J., and Morrison, D. C. (2001) J. Immunol. 166, 6855-

6860

14. Dziarski, R., Tapping, R. I., and Tobias, P. S. (1998) J. Biol. Chem. 273, 8680-8690

15. Juan, T. S.-C., Hailman, E., Kelley, M. J., Busse, L. A., Davy, E., Empig, C. J., Narhi, L.

O., Wright, S. D., and Lichenstein, H. S. (1995) J. Biol. Chem. 270, 17237-17242

by guest on January 31, 2018http://w

ww

.jbc.org/D

ownloaded from

Page 26: 1 The origin of the synergistic effect of muramyldipeptide with

26

16. Siriwardena, A., Jorgenson, M. R., Wolfert, M. A., Vandenplas, M. L., Moore, J. N., and

Boons, G.-J. (2001) J. Am. Chem. Soc. 123, 8145-8146.

17. Tapping, R. I., Akashi, S., Miyake, K., Godowski, P. J., and Tobias, P. S. (2000) J.

Immunol. 165, 5780-5787

18. Chow, J. C., Young, D. W., Golenbock, D. T., Christ, W. J., and Gusovsky, F. (1999) J.

Biol. Chem. 274, 10689-10692

19. Flak, T. A., Heiss, L. N., Engle, J. T., and Goldman, W. E. (2000) Infect. Immun. 68,

1235-1242

20. Gupta, D., Kirkland, T. N., Viriyakosol, S., and Dziarski, R. (1996) J. Biol. Chem. 271,

23310-23316

21. Lee, J.-D., Kravchenko, V., Kirkland, T. N., Han, J., Mackman, N., Moriarty, A.,

Leturcq, D., Tobias, P. S., and Ulevitch, R. J. (1993) Proc. Natl. Acad. Sci. U. S. A. 90,

9930-9934

22. Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J., and Mathison, J. C. (1990)

Science 249, 1431-1433

23. Dziarski, R., Ulmer, A. J., and Gupta, D. (2000) Chem. Immunol. 74, 83-107

24. Beutler, B. (2000) Curr. Opin. Immunol. 12, 20-26

25. Jiang, Q., Akashi, S., Miyake, K., and Petty, H. R. (2000) .J. Immunol. 165, 3541-3544

26. Schwandner, R., Dziarski, R., Wesche, H., Rothe, M., and Kirschning, C. J. (1999) J.

Biol. Chem. 274, 17406-17409

27. Yoshimura, a., Lien, E., Ingalls, R. R., Tuomanen, E., Dziarski, R., and Golenbock, D.

(1999) J. Immunol. 163, 1-5

by guest on January 31, 2018http://w

ww

.jbc.org/D

ownloaded from

Page 27: 1 The origin of the synergistic effect of muramyldipeptide with

27

28. Yang, H., Young, D. W., Gusovsky, F., and Chow, J. C. (2000) J. Biol. Chem. 275,

20861-20866

29. Triantafilou, K., Triantafilou, M., and Dedrick, R. L. (2001) Nature Immunol. 2, 338-345

30. Weidemann, B., Schletter, J., Dziarski, R., Kusumoto, S., Stelter, F., Rietschel, E. T.,

Flad, H.-D., and Ulmer, A. J. (1997) Infect. Immun. 65, 558-564

31. Jongeneel, C. V. (1995) Immunobiology 193, 210-216

32. Mijatovic, T., Houzet, L., Defrance, P., Droogmans, L., Huez, G., and Kruys, V. (2000)

Eur. J. Biochem. 267, 6004-6011

33. Crawford, E. K., Ensor, J. E., Kalvakolanu, I., and Hasday, J. D. (1997) J. Biol. Chem.

272, 21120-21127

34. Wang, Z.-M., Liu, C., and Dziarski, R. (2000) J. Biol. Chem. 275, 20260-20267

35. Takeuchi, O., Takeda, K., Hoshino, K., Adachi, O., Ogawa, T., and Akira, S. (2000)

Internat. Immunol. 12, 113-117

36. Ribi, E. E., Cantrell, J. L., Von Eschen, K. B., and Schwartzman, S. M. (1979) Cancer

Res. 39, 4756-4759

37. van Langevelde, P., Ravensbergen, E., Grashoff, P., Beekhuizen, H., Groeneveld, P. H.,

and van Dissel, J. T. (1999) Antimicrob. Agents Chemother. 43, 2984-2989

by guest on January 31, 2018http://w

ww

.jbc.org/D

ownloaded from

Page 28: 1 The origin of the synergistic effect of muramyldipeptide with

28

FOOTNOTES

1. This work was supported in part by grants from the Georgia Heart Association

(0051229B) and National Institutes of Health (GM61761-02).

2. The abbreviations used are: PGN, peptidoglycan; LPS, lipopolysaccharide; MDP,

muramyldipeptide (N-Acetylmuramyl-L-alanyl-D-isoglutamine); TLR, Toll-like receptor;

TNF, tumor necrosis factor; FCS, fetal calf serum; RT-PCR, reverse transcription-

polymerase chain reaction; Emax, maximum response; EC50,concentration producing 50%

activity; t, time of dissociation; k, dissociation rate constant; t1/2, half-life; mAb(s),

monoclonal antibody(ies); IL, interleukin; s, soluble.

by guest on January 31, 2018http://w

ww

.jbc.org/D

ownloaded from

Page 29: 1 The origin of the synergistic effect of muramyldipeptide with

29

FIGURE LEGENDS

Fig. 1. Effect of MDP on LPS and PGN concentration-response curves. Mono Mac 6

cells were preincubated with 100 µg/ml MDP or medium as control for 30 min at 37oC. After 6

hours of stimulation with increasing concentrations of LPS (Fig. 1a) or PGN (Fig. 1b) as

indicated TNF-α was determined. Stimulation with MDP alone (100 µg/ml) resulted in a TNF-α

concentration of 71 + 21 pg/ml.

Fig. 2. Induction of TNF- mRNA and TNF- production by Mono Mac 6 cells treated

with LPS, PGN and MDP. Mono Mac 6 cells were stimulated with medium alone, medium

containing 30 ng/ml LPS, or 100 µg/ml PGN in the absence or the presence of 100 µg/ml MDP

for 90 min before RNA was isolated for RT-PCR analysis of TNF-α message (40 PCR cycles)

(Fig. 2a). mRNA of the 18S ribosomal gene amplified under the same conditions was used as

the internal controls. Supernatants of the same samples were assayed for TNF-α protein (Fig.

2b).

Fig. 3. Comparison of MDP with LPS on TNF- mRNA and TNF- protein levels.

Mono Mac 6 cells were stimulated with medium alone, increasing concentrations of LPS (0.01 -

100 ng/ml), or increasing concentrations of MDP (0.01 - 300 µg/ml) as indicated. After 90 min,

TNF-α production was measured (Fig. 3a), and total RNA was extracted and subjected to RT-

PCR analysis for detection of TNF-α mRNA (Fig. 3b).

Fig. 4. TNF- mRNA stability in Mono Mac 6 cells treated with different combinations

of stimuli. Mono Mac 6 cells were stimulated with medium alone, medium containing 30 ng/ml

LPS, or 100 µg/ml PGN in the absence or the presence of 100 µg/ml MDP for 90 min. At this

by guest on January 31, 2018http://w

ww

.jbc.org/D

ownloaded from

Page 30: 1 The origin of the synergistic effect of muramyldipeptide with

30

time, new transcription was stopped with actinomycin D (10 µg/ml). Over a period of 2 hours,

total RNA was isolated at different time points and TNF-α mRNA was measured by RT-PCR.

Treatment with 10 µg/ml actinomycin D did not affect cell viability as judged by cellular

exclusion of trypan blue.

Fig. 5. Effect of anti-CD14 mAbs on MDP synergism with LPS and PGN. Mono Mac 6

cells were preincubated with anti-CD14 mAb MEM-18 (16 µg/ml), anti-CD14 mAb MY4 (20

µg/ml), or medium as control for 30 min at 4oC. TNF-α was measured after 6 hours of

stimulation with 10 ng/ml LPS (Fig. 5a) or 10 µg/ml PGN (Fig. 5b) either in the absence (LPS or

PGN alone) or presence (MDP & LPS or PGN) of 100 µg/ml MDP. No effects were observed

for the control antibodies IgG1 (MEM-18) and IgG2b (MY4).

Fig. 6. Effect of anti-TLR4 on synergistic effect between MDP and LPS. Mono Mac 6

cells were preincubated with anti-TLR4 mAb (40 µg/ml) or medium as control (alone) for 30

min at 4oC. After 6 hours of stimulation with MDP (100 µg/ml), LPS (10 ng/ml), or MDP

together with LPS at the same concentrations, TNF-α production was measured. (NA = not

analyzed). Preincubation with the control antibody IgG2a had no effect.

Fig. 7. Effect of anti-TLR2 on synergistic effect between MDP and PGN. Mono Mac 6

cells were preincubated with anti-TLR2 mAb (40 µg/ml) or medium as control (alone) for 30

min at 4oC. After 6 hours of stimulation with MDP (100 µg/ml), PGN (10 µg/ml), or MDP

together with PGN at the same concentrations, TNF-α production was measured. (NA = not

analyzed). Preincubation with the control antibody IgG2a had no effect.

by guest on January 31, 2018http://w

ww

.jbc.org/D

ownloaded from

Page 31: 1 The origin of the synergistic effect of muramyldipeptide with

31

Fig. 8. Effect of MDP on the [3H]LPS off rate from Mono Mac 6 cells. After Mono Mac 6

cells were preincubated with [3H]LPS (30 ng/ml) for 1 hour at 37oC, unlabeled (cold) LPS (10

µg/ml) or a mixture of MDP (100 µg/ml) and unlabeled LPS (10 µg/ml) were added to the cells.

Cells were harvested at various time points and cell-associated 3H was counted.

by guest on January 31, 2018http://w

ww

.jbc.org/D

ownloaded from

Page 32: 1 The origin of the synergistic effect of muramyldipeptide with

32

TABLES

Table 1 Relative TNF-α gene expression by Mono Mac 6 cells after stimulation with

different stimuli followed in time.

Relative Quantity of TNF- mRNA(95% confidence intervals)

30min

60min

90min

120min

Untreated 1.0 - 1.0 0.8 - 1.2 1.0 - 1.0 0.9 - 1.1

LPS (30 ng/ml) 1.1 - 1.6 17.3 - 18.1 15.8 - 19.4 11.5 - 12.5

PGN (100 µg/ml) 1.9 - 2.2 29.1 - 32.1 17.5 - 22.5 13.0 - 15.4

MDP (100 µg/ml) 0.9 - 1.5 3.2 - 4.2 7.2 - 8.5 2.4 - 2.6

MDP (100 µg/ml) & LPS (30 ng/ml) 1.2 - 1.4 21.2 - 22.5 26.8 - 33.6 8.9 - 11.7

MDP (100 µg/ml) & PGN (100 µg/ml) 2.0 - 2.3 22.4 - 30.4 27.1 - 31.2 14.2 - 18.6

Table 2 Effect of anti-CD14 mAb MY4 on the induction of TNF-α mRNA by Mono Mac 6

cells incubated with different stimuli for 90 min.

Relative Quantity of TNF- mRNA(95% confidence intervals)

Control MY4(20 µg/ml)

Untreated 0.9 - 1.2 1.0 - 1.1

LPS (30 ng/ml) 7.7 - 9.7 1.0 - 1.9

PGN (100 µg/ml) 7.1 - 8.9 6.2 - 8.2

MDP (100 µg/ml) 4.5 - 5.5 4.9 - 5.7

MDP (100 µg/ml) & LPS (30 ng/ml) 12.3 - 15.7 5.0 - 6.3

MDP (100 µg/ml) & PGN (100 µg/ml) 9.2 - 11.2 8.1 - 10.9

by guest on January 31, 2018http://w

ww

.jbc.org/D

ownloaded from

Page 33: 1 The origin of the synergistic effect of muramyldipeptide with

33

Table 3 Effect of anti-TLR mAbs on the induction of TNF-α mRNA by Mono Mac 6 cells

incubated with different stimuli for 90 min.

Relative Quantity of TNF- mRNA(95% confidence intervals)

Control Anti-TLR2(40 µg/ml)

Anti-TLR4(40 µg/ml)

Untreated 1.0 – 1.0 0.8 – 1.0 0.8 – 0.9

LPS (30 ng/ml) 13.0 – 14.3 NA 10.3 – 12.4

PGN (100 µg/ml) 10.9 – 11.6 7.8 – 8.8 NA

MDP (100 µg/ml) 6.1 – 8.6 6.5 – 8.3 6.8 – 7.9

MDP (100 µg/ml) & LPS (30 ng/ml) 22.5 – 23.0 NA 16.7 – 18.1

MDP (100 µg/ml) & PGN (100 µg/ml) 17.4 – 19.5 15.0 – 16.3 NA

Note: NA = not analyzed

by guest on January 31, 2018http://w

ww

.jbc.org/D

ownloaded from

Page 34: 1 The origin of the synergistic effect of muramyldipeptide with

34

FIGURES

by guest on January 31, 2018http://w

ww

.jbc.org/D

ownloaded from

Page 35: 1 The origin of the synergistic effect of muramyldipeptide with

35

by guest on January 31, 2018http://w

ww

.jbc.org/D

ownloaded from

Page 36: 1 The origin of the synergistic effect of muramyldipeptide with

36

by guest on January 31, 2018http://w

ww

.jbc.org/D

ownloaded from

Page 37: 1 The origin of the synergistic effect of muramyldipeptide with

37

by guest on January 31, 2018http://w

ww

.jbc.org/D

ownloaded from

Page 38: 1 The origin of the synergistic effect of muramyldipeptide with

38

by guest on January 31, 2018http://w

ww

.jbc.org/D

ownloaded from

Page 39: 1 The origin of the synergistic effect of muramyldipeptide with

39

by guest on January 31, 2018http://w

ww

.jbc.org/D

ownloaded from

Page 40: 1 The origin of the synergistic effect of muramyldipeptide with

Margreet A. Wolfert, Thomas F. Murray, Geert-Jan Boons and James N. Moorepeptidoglycan

The origin of the synergistic effect of muramyldipeptide with endotoxin and

published online July 31, 2002J. Biol. Chem. 

  10.1074/jbc.M204885200Access the most updated version of this article at doi:

 Alerts:

  When a correction for this article is posted• 

When this article is cited• 

to choose from all of JBC's e-mail alertsClick here

by guest on January 31, 2018http://w

ww

.jbc.org/D

ownloaded from